Showing results (21-30 of 66) with videos related to
Sort By:
Pageof 7
Journal of the American Geriatrics Society|April 10, 2023
Cell cycle arrest: A breakthrough in the supportive care of older cancer patientsClaire Falandry, Alan List, Lodovico BalducciLeukemia|February 16, 2018
A decade of progress in myelodysplastic syndrome with chromosome 5q deletionAlan List, Benjamin L Ebert, Pierre FenauxFrontiers in Oncology|October 9, 2014
PP2A: The Achilles Heal in MDS with 5q DeletionDavid A Sallman, Sheng Wei, Alan ListEuropean Journal of Haematology|December 23, 2018
Molecular pathogenesis of myelodysplastic syndromes with deletion 5qJung-Hoon Lee, Alan List, David A SallmanFrontiers in Oncology|July 6, 2016
Unraveling the Pathogenesis of MDS: The NLRP3 Inflammasome and Pyroptosis Drive the MDS PhenotypeDavid A Sallman, Thomas Cluzeau, Ashley A Basiorka, et al.Clinical Lymphoma, Myeloma & Leukemia|October 14, 2017
SOHO State of the Art Update and Next Questions: Biology and Treatment of Myelodysplastic SyndromesDavid A Sallman, Tiffany N Tanaka, Alan List, et al.Cancer Genetics and Cytogenetics|November 26, 2008
Myelodysplastic syndromes with del(5q): indications and strategies for cytogenetic testingClaudia Haferlach, Ulrike Bacher, Ramon Tiu, et al.American Journal of Hematology|June 20, 2015
A multicenter, phase II study of maintenance azacitidine in older patients with acute myeloid leukemia in complete remission after induction chemotherapyPatrick T Griffin, Rami S Komrokji, Carlos M De Castro, et al.Annals of Hematology|September 11, 2013
Lenalidomide as a disease-modifying agent in patients with del(5q) myelodysplastic syndromes: linking mechanism of action to clinical outcomesAristoteles Giagounidis, Ghulam J Mufti, Pierre Fenaux, et al.Leukemia Research|March 2, 2016
T-cell large granular lymphocyte proliferation in myelodysplastic syndromes: Clinicopathological features and prognostic significanceXiaohui Zhang, Lubomir Sokol, John M Bennett, et al.Pageof 7